You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Klacid Granules for Oral Suspension

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Mönchengladbach (20 mg tablet rivaroxaban, 20 mg rivaroxaban, granules for oral suspension)

Completed
  • Healthy Volunteers
  • 20 mg tablet rivaroxaban
  • 20 mg rivaroxaban, granules for oral suspension
  • Mönchengladbach, Nordrhein-Westfalen, Germany
    CRS Clinical-Research-Services Mönchengladbach GmbH
Jan 25, 2021

Thromboembolic Disorders Trial in Mönchengladbach (Rivaroxaban (Xarelto, BAY59-7939))

Completed
  • Thromboembolic Disorders
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Mönchengladbach, Nordrhein-Westfalen, Germany
    CRS Clinical-Research-Services Mönchengladbach GmbH
Jan 20, 2021

Drug Drug Interaction Trial in Porto (Givinostat, Clarithromycin)

Completed
  • Drug Drug Interaction
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Apr 26, 2023

COPD Trial in Beijing (Qingkepingchuan Granules, conventional treatment)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Qingkepingchuan Granules
  • conventional treatment
  • Beijing, China
    Beijing University of Chinese Medicine
Nov 21, 2023

Heartburn, Acid-dependent Diseases of the Gastrointestinal Tract, Symptomatic Treatment of Gastric and Duodenal Ulcers Trial in

Not yet recruiting
  • Heartburn
  • +2 more
  • Moscow, Russian Federation
  • +1 more
Oct 19, 2023

Relative Bioavailability Trial (PanCytoVir™ 100 mg/mL oral suspension, Probenecid 500 mg)

Not yet recruiting
  • Relative Bioavailability
  • PanCytoVir™ 100 mg/mL oral suspension
  • Probenecid 500 mg
  • (no location specified)
Sep 5, 2023

Healthy Subjects, Pharmacokinetics of 14C-labeled of LXI-15028 Trial in Suzhou ([14C]LXI-15028)

Completed
  • Healthy Subjects
  • Pharmacokinetics of 14C-labeled of LXI-15028
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
May 22, 2023

COVID-19, Child, Only Trial in Qingdao (Jinzhen oral liquid or Jinhuaqinggan granules)

Recruiting
  • COVID-19
  • Child, Only
  • Jinzhen oral liquid or Jinhuaqinggan granules
  • Qingdao, Shandong, China
    Phase I Clinical Research Center
Aug 17, 2022

Imumune Thrombocytopenia(ITP) Human Mass Balance Trial in Suzhou (HMPL-523, 150 µCi [14C]HMPL-523)

Recruiting
  • Imumune Thrombocytopenia(ITP) Human Mass Balance
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 12, 2023

Normal Healthy Volunteers Trial in Las Vegas (Lofexidine (granules for reconstitution), LUCEMYRA (lofexidine) tablets)

Completed
Has Results
  • Normal Healthy Volunteers
  • Lofexidine (granules for reconstitution)
  • LUCEMYRA (lofexidine) tablets
  • Las Vegas, Nevada
    Novum Pharmaceutical Research Services
May 19, 2022

Menopause Trial in Shatin (Modified Guizhi Fuling granules, Placebo)

Not yet recruiting
  • Menopause
  • Modified Guizhi Fuling granules
  • Placebo
  • Shatin, Hong Kong
    School of Chinese Medicine
Oct 4, 2023

Relative Bioavailability Trial (PanCytoVir™)

Not yet recruiting
  • Relative Bioavailability
  • (no location specified)
Sep 5, 2023

Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Xiaopi granules
  • +2 more
  • (no location specified)
Nov 22, 2023

Therapeutic Equivalency Trial in Bron, Bordeaux, Marseille (Ped-TMZ)

Completed
  • Therapeutic Equivalency
  • Bron, Rhône, France
  • +2 more
Feb 21, 2022

Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy Trial in Worldwide (Sparsentan)

Recruiting
  • Focal Segmental Glomerulosclerosis
  • +4 more
  • Wilmington, Delaware
  • +32 more
Jan 10, 2023

Lianhua Qingwen in Treating Patients Infected With Omicron

Not yet recruiting
  • COVID-19 Pneumonia
  • The group of patients who received Lianhua Qingwen orally
  • The group of patients who did not receive Lianhua Qingwen orally
  • (no location specified)
Mar 20, 2023

Eosinophilic Esophagitis Trial in Zürich (Mesalamine Oral Product)

Not yet recruiting
  • Eosinophilic Esophagitis
  • Mesalamine Oral Product
  • Zürich, Switzerland
    Universitätsspital Zürich
Aug 3, 2022

Alzheimer Trial in Amsterdam (REM0046127 High Dose, REM0046127 Low Dose, Placebo)

Recruiting
  • Alzheimer Disease
  • REM0046127 High Dose
  • +2 more
  • Amsterdam, Netherlands
    BRC Amsterdam
Jul 26, 2022

Edema Due to Heart Failure or Cirrhosis Trial in Hyderabad, (Spironolactone Oral Suspension)

Completed
  • Edema Due to Heart Failure or Cirrhosis
  • Spironolactone Oral Suspension
  • Hyderabad,, Telangana, India
    ClinSync Clinical Research Pvt. Ltd.
Aug 28, 2023

Gouty Arthritis Trial in China (Qingzhu Granules, Qingzhu Granules Placebo)

Not yet recruiting
  • Gouty Arthritis
  • Qingzhu Granules
  • Qingzhu Granules Placebo
  • Beijing, China
  • +25 more
Oct 6, 2023

Poor Ovarian Response Trial in Beijing (Jiajian Guishen granules, coenzyme Q10)

Not yet recruiting
  • Poor Ovarian Response
  • Jiajian Guishen granules
  • coenzyme Q10
  • Beijing, Beijing, China
  • +1 more
Oct 18, 2023

Parkinson Disease Trial in Tempe (CVN424)

Completed
  • Parkinson Disease
  • Tempe, Arizona
    Celerion
Nov 30, 2022

Colorectal Cancer Trial in China (Huaier granule)

Not yet recruiting
  • Colorectal Cancer
  • Huaier granule
  • Harbin, Heilongjiang, China
  • +8 more
Oct 15, 2023

Healthy Volunteers Trial in Nottingham (Part 1: Belumosudil 40 mg/mL Sequence ABFCED, Part 1: Belumosudil 40 mg/mL Sequence

Completed
  • Healthy Volunteers
  • Part 1: Belumosudil 40 mg/mL Sequence ABFCED
  • +11 more
  • Nottingham, England, United Kingdom
    Quotient Sciences
May 10, 2022

Primary Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial (Huaier granule)

Not yet recruiting
  • Primary Ovarian Cancer
  • +2 more
  • Huaier granule
  • (no location specified)
Mar 29, 2023